Clinical trial
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts…
NCT00293384 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00293384 |
|---|---|
| Title | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant |
| Official title | Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nausea and Vomiting, Neuroblastoma and 2 more |
| Intervention type | Drug |
| Interventions | Aprepitant, Cyclophosphamide, Dexamethasone, Granisetron hydrochloride |
| Enrollment | 40 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Feb 1, 2012 |
| First posted | Feb 17, 2006 |
| Last update posted | Mar 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: